Blog

Dr. Maloney on CAR T-Cell Product in B-Cell Lymphoma – OncLive


OncLive

Dr. Maloney on CAR T-Cell Product in B-Cell Lymphoma
OncLive
David Maloney, MD, PhD, professor of medicine, Division of Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the preliminary safety data of the chimeric antigen receptor (CAR) T-cell
Impressive Results for CAR T-cell Therapy JCAR017 in B-cell …Lymphoma News Today



all 5 news articles »

2017-12-19 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.